Cargando…
Tocilizumab and COVID-19
The number of cases in COVID-19 pandemic is rising rapidly. There has not been a single effective proven medication for COVID-19 disease. Highest mortality has been reported among subjects who develop acute respiratory disease (ARDS). The histopathological analysis of lung specimens has given rise t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Jaypee Brothers Medical Publishers
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584849/ https://www.ncbi.nlm.nih.gov/pubmed/33132549 http://dx.doi.org/10.5005/jp-journals-10071-23608 |